Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists use motion capture to track eye skin aging

NCT ID NCT07080320

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study uses motion capture technology to precisely measure how the skin around the eyes moves and changes with age. Researchers will compare 60 healthy women in two age groups (18-33 and 50-65) to understand skin dynamics during facial expressions and jumps. The goal is to validate motion capture as a tool for studying aging and testing treatments like tightening products.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could provide a new, precise way to measure skin aging and the effects of treatments like creams or massages around the eyes.
What could go wrong
This is an early observational study with only 60 healthy women, so results may not apply to men or people with different skin types. It measures movement, not health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Sep 2025

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female participants * Caucasian, Fitzpatrick skin types I-III * BMI between 18.5 and 27, healthy participants * Aged 18 to 65 years (inclusive) * Not under guardianship or curatorship * Informed written consent * Social security affiliation * Non-smokers for at least 5 years * No excessive UV exposure (artificial or natural) in the last 3 weeks prior to the study or during the study Exclusion Criteria: * Severe skin disorders preventing the application of electrodes or photo-reflective markers * Neurovascular history affecting the face * Ongoing treatments influencing facial tissues (e.g., corticosteroids) * Current sleep disorders * Psychiatric conditions or social interaction impairments * Inner ear or balance disorders * Osteoporosis, recent fractures, or fragile bone conditions * Pregnant or breastfeeding women * Under guardianship, curatorship, or legal protection

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Aging are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHRU Amiens

    Amiens, 80480, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.